Schistosoma Mansoni: Clinical Trials

4 trials for Schistosoma Mansoni, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting. 4 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Not yet recruiting 1
Phase 22Completed 1, Not yet recruiting 1

Follow Schistosoma Mansoni: new trials by email Literature Review of Schistosoma Mansoni trials Research Report on Schistosoma Mansoni

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis
Praziquantel 40 mg/kg per dose given once annually, Praziquantel 40 mg/kg given three times per year - Schistosomiasis, Schistosoma Mansoni
Phase 2 / Phase 3Not yet recruitingRhode Island Hospital6002026-11-012026-08-12
Clinical Evaluation of UjiplusĀ® Against Schistosoma Mansoni
UjiplusĀ®, Praziquantel 400mg - Schistosoma Mansoni
Phase 2 / Phase 3CompletedKenya Medical Research Institute4002021-05-062022-07-12
Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children
Praziquantel, Artesunate + Mefloquine - Schistosoma Haematobium, Schistosoma Mansoni
Phase 3CompletedInstitute of Tropical Medicine, Belgium7262019-10-142021-04-05
A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni
Artesunate+Sulfamethoxypyrazine/pyrimethamine, Praziquantel - Schistosoma Mansoni
Phase 3CompletedKenya Medical Research Institute2122009-10-012010-01-22

Narrower conditions

Schistosomiasis (4)  ·  Hypertension, Portal (1)  ·  Liver Cirrhosis (1)  ·  Schistosomiasis haematobia (1)

Broader conditions

Helminthiasis (4)  ·  Infections (4)  ·  Parasitic Diseases (4)  ·  Trematode Infections (4)  ·  Vector Borne Diseases (4)  ·  Digestive System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Fibrosis (1)  ·  Liver Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Urinary Tract Infections (1)  ·  Urogenital Diseases (1)

Interventions

Praziquantel (4)  ·  Artesunate (1)  ·  Mefloquine (1)  ·  Pyrimethamine (1)

Sponsors

Kenya Medical Research Institute (2)  ·  Institute of Tropical Medicine, Belgium (1)  ·  Rhode Island Hospital (1)

Countries

Kenya (2)  ·  Senegal (1)  ·  Uganda (1)

Top investigators

Elijah M Songok, PhD (1)  ·  Moustapha Mbow, MD (1)  ·  Pauline N Mwinzi, PhD (1)

Results publications

PMID 20705516, PMID 34168029, PMID 38177851

NIH funding

R01AI184979 (1)